I
IONS icon

InceptionR’s Ionis Pharmaceuticals IONS Stock Holding History

InceptionR’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Sell
16,821
-1,029
-6% -$81.2K 0.3% 91
2025
Q4 		$1.41M Buy
17,850
+10,229
+134% +$770K 0.39% 41
2025
Q3 		$499K Buy
+7,621
New +$372K 0.12% 312
2025
Q1 		– Sell
-14,390
Closed -$503K – 692
2024
Q4 		$503K Buy
+14,390
New +$538K 0.11% 332
2024
Q3 		– Sell
-17,289
Closed -$824K – 755
2024
Q2 		$824K Buy
+17,289
New +$709K 0.23% 152
2023
Q2 		– Sell
-12,790
Closed -$457K – 516
2023
Q1 		$457K Buy
+12,790
New +$480K 0.15% 261

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

InceptionR's IONS Position: Q1 2026 in Review

InceptionR reduced its Ionis Pharmaceuticals (IONS) stake by 5.8% in Q1 2026, selling an estimated $81.2K and leaving 16,821 shares worth $1.26M. The position accounts for 0.3% of the portfolio, ranked #91.

InceptionR first reported a position in IONS in Q1 2023 and has held it in 6 quarters since. The position peaked at $1.41M in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • InceptionR held 16,821 shares of Ionis Pharmaceuticals worth $1.26M as of Q1 2026.
  • InceptionR sold 1,029 Ionis Pharmaceuticals shares in Q1 2026, an estimated $81.2K.
  • Ionis Pharmaceuticals made up 0.3% of InceptionR's portfolio in Q1 2026, its #91 holding.
  • InceptionR first reported a position in Ionis Pharmaceuticals in Q1 2023 and has held it in 6 quarters since.
  • InceptionR's Ionis Pharmaceuticals position peaked at $1.41M in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.